Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Cindy L. O'byrant"'
Autor:
Christopher H. Lieu, Todd M. Pitts, Cindy L. O’byrant, Jennifer L. Spratlin, Stephen Leong, Sarah Eppers, Sujatha Nallapreddy, S. Gail Eckhardt, Elizabeth R. Kessler, Madeleine A. Kane, Erica L. Bradshaw-Pierce, Wells A. Messersmith, Colin D. Weekes, Elizabeth Freas
Background Vandetanib is a multitargeted tyrosine kinase inhibitor that affects vascular endothelial growth factor receptor (VEGF), epidermal growth factor (EGF), and rearranged during transfection (RET) mediated receptors which are important for gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe4e0d5baa3ed421cbdcf0a4384b59c
https://europepmc.org/articles/PMC4788525/
https://europepmc.org/articles/PMC4788525/
